Lv1
40 积分 2025-10-14 加入
Efficacy and Safety of Olomorasib in Combination With Pembrolizumab in Treatment of Patients With KRAS G12C-Mutant Advanced NSCLC
7天前
已完结
Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients with HER2-Mutant Non-Small Cell Lung Cancer across Treatment Lines: Evidence from the TRACER/HERTras Real-World Cohort
8天前
已完结
Repotrectinib in ROS1 Fusion–Positive Non–Small-Cell Lung Cancer
14天前
已完结
Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia
29天前
已完结
Thrombopoietin-Receptor Agonists in Chemotherapy-Induced Thrombocytopenia
29天前
已完结
Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or MetastaticROS1Fusion–Positive Non–Small-Cell Lung Cancer
29天前
已关闭
A matching-adjusted indirect comparison of first-line lorlatinib and alectinib for the treatment of ALK-rearranged advanced non-small cell lung cancer
1个月前
已完结
Efficacy and safety of garsorasib in patients with KRAS G12C-mutated advanced pancreatic cancer
2个月前
已完结
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Efbemalenograstim Alfa (F-627), a Novel Long-Acting rhG-CSF, in Healthy Chinese Participants: An Open-Label, Single-Center Phase I Study
2个月前
已完结
Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
2个月前
已完结
皖公网安备34019202002308
